EyePoint Pharmaceuticals' lead product, EYP-1901, shows promising phase 2 results for wet AMD and DME. Read more about EYPT ...
Detailed price information for Eyepoint Pharmaceuticals Inc (EYPT-Q) from The Globe and Mail including charting and trades.
On Oct. 1, I needed a break from the reality of antisemitism. That day, Iran had launched 200 ballistic missiles against ...
Tuna and salmon, both popular seafood choices, offer distinct nutritional benefits. While both are rich in protein and ...
Experts and advocates to provide important strategic input and clinical expertise as ACELYRIN completes its Phase 2 trial of lonigutamab in TED and prepares to initiate Phase 3 program in first quarter ...
The pair don’t see eye-to-eye, Trump wants the president to have a say in ... Confirmed human cases have risen to 46 as of ...
A retrospective analysis of 198 eyes (average age 59) was conducted, focusing on best-corrected visual acuity ... The study concluded that OCT is increasingly replacing FA and PRP in retinal disease ...
Halloween brings out large crowds, dark skies, and people in masks, what experts call ingredients for a perfect recipe for ...
The siren and lights during a traffic stop are unnerving to most people, but for autistic drivers, the situation can lead to ...